TAST

product development, namely, development of cell therapy products; research services in the field of cell separation; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; genetic testing, namely, biological information check, for medical research use; product development, namely, biologics development; research in the field of biologics; biological analysis; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; DNA sequence analysis for scientific research purposes

immunotherapy services related to the treatment of cancers; medical services relating to the removal, treatment and processing of human cells for the purpose of stem cell therapy; analysis of human tissues for medical treatment purposes; providing a database featuring information regarding immune cells for medical purposes; medical services relating to the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow for medical treatment purposes; medical and health services relating to DNA screening for medical purposes; genetic testing for medical purposes; provision of gene therapy for medical purposes; medical analysis services for the diagnosis and prognosis of cancer; medical analysis services for the diagnosis and prognosis of cancer, namely, RNA or DNA analysis for cancer diagnosis and prognosis; providing information in the field of cancer prevention, screening, diagnosis and treatment; medical analysis services for diagnostic and treatment purposes provided by medical laboratories